The Impact of Supplementation With Multi-vitamins/Minerals, With and Without Fatty Acids, on Impulsivity and Aggression
Launched by SWANSEA UNIVERSITY · Mar 19, 2012
Trial Information
Current as of September 17, 2025
Completed
Keywords
ClinConnect Summary
Objective: To consider whether aggression and impulsivity respond to multi-vitamins / minerals or fatty acid supplementation and whether there is a synergistic interaction?
In a between subjects design four groups will be contrasted. Those who for three months:
1. Receive two placebos
2. Receive multi-vitamin / mineral plus a placebo
3. Receive fatty acids plus placebo
4. Receive multi-vitamin / mineral plus fatty acids.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Only male participants are being studied of self-reported good health who do not regularly consume seafood. They will be of a minimum age of 18 years of age and a maximum of 35 years of age. They will not be currently taking any medication and have no acute or chronic medical condition
- Exclusion Criteria:
- • If they had consumed n-3 fatty acid ro vitamin/mineral supplements during the previous six months.
- • If they have any history of food intolerance
About Swansea University
Swansea University is a leading research institution located in the United Kingdom, renowned for its commitment to innovative healthcare solutions and advancements in clinical research. With a focus on interdisciplinary collaboration, the university conducts a range of clinical trials aimed at improving patient outcomes and enhancing medical knowledge. Leveraging cutting-edge facilities and a team of expert researchers, Swansea University is dedicated to fostering an environment that prioritizes ethical standards, scientific rigor, and the translation of research findings into real-world applications. Through its dedicated clinical trial initiatives, the university plays a pivotal role in advancing evidence-based practices in the healthcare sector.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Swansea, Wales, United Kingdom
Patients applied
Trial Officials
David Benton, D.Sc
Principal Investigator
Swansea University, Swansea, United Kingdom, SA2 8PP
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials